Education and Course Division

Chair: Janja Marc



Strategic Objectives of Education and Course Division 2015-2017

1. To establish a structure for the Division composed of at least 3 full members, associate members and representatives of corporate and institutional membership

2. To organize at least one educational event every year, such as  summer or winter schools and short Advanced Courses

3. To organize educational sessions in collaboration with other European organizations

4. To organize training activities in collaboration with and tailored to the needs of industry

5. To create a committee focusing on developing teaching programs for medical and pharmaceutical schools

6. To prepare educational materials for the website


ESPT Educational Activities have the following objectives:

 1. To provide students and health professionals with comprehensive training and updated knowledge in the multidisciplinary field of pharmacogenomics and theranostics

 2. To provide information on Personalized Medicine and theranostics based on an integrated approach incorporating all facets of “New Genetics” (pharmacogenomics, nutrigenomics, toxicogenomics, immunogenomics, epigenomics)

 3. To understand and elaborate the importance of Adverse Drug Reactions (ADRs) as a long-standing and largely neglected major medical problem

 4. To understand the importance of pharmacogenetic testing in routine medical practice for better and safe treatment

 5. To understand importance of biostatistics and bioinformatics for pharmacogenomics and theranostics

 6. To understand the convergence between systems biology and pharmacogenomics

 7. To understand the position of pharmacogenomics and theranostics in Evidence Based Medicine (EBM)

 8. To discuss ethical issues in obtaining, using, and distributing genetic information with an emphasis on specific ethical issues related to pharmacogenomics

 9. To encourage interaction between specialists in the various aspects of pharmacogenomics, theranostics and personalised medicine

 10. To bridge the gap between available knowledge generated through basic and clinical research and clinical application

The target audience of educational activities includes physicians; pharmacists; biologists; scientists and research staff investigators; graduate students (medical, pharmacy, science, etc); other health care professionals (e.g. nurses, nutritionists); pharmaceutical industry scientists, sales personel, and managers; hospital and insurance company administrators and economists; key decision makers (e.g. politicians, government administrators in health care)

The subjects that should be covered in every educational activity of EPST should be tailored according to the needs of the audience. Indicatively, the topics for a comprehensive general educational meeting lasting 2-4 days should include the following:

 1. Basics of molecular genetics

 2. Drug metabolism

 3. Drug-drug interactions

 4. Drug safety and pharmacovigilance

 5. Therapeutic drug monitoring (TDM) as a tool in theranostics

 6. Pharmacogenetic applications in specific clinical areas, such as oncology, immunology, cardiology, asthma, diabetes and psychiatry

 7. Interpretation of Pharmacogenetic testing results by personalised reports

 8. Psychological and social aspects of pharmacogenomics and theranostics

 9. Pharmacoecomics

 10. Nutrigenomics and its practical applications

 11. Epigenomics and pharmacoepigenomics

 12. Interaction of genetics and environmental factors in development and treatment of disease

 13. Evidence-Based Medicine

 14. Molecular biology techniques and high-throughput technologies

 15. Bioinformatics and biostatistics

 16. Ethical aspects of genomics

 17. Patient rights, application of medical privacy and confidentiality for genetics

These activities will be developed under the responsibility of a specific committee on education (Vangelis Manopoulos, Janja Marc, David Gurwitz, Angela Brand and Ingolf Cascorbi).


Working groups:

Curriculae and education for pharmacogenomics and personalized medicine - Joint committee with EFLM (Janja Marc)

Pharmacogenomics information for generic drugs (Vangelis Manolopulos)